Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1926247 | Archives of Biochemistry and Biophysics | 2009 | 9 Pages |
Cofactor-independent glutamate racemases (GRs) that supply the d-glutamate required for biosynthesis of the peptidoglycan that encapsulates bacterial cells are attractive targets for the development of antibacterial drugs. Recombinant GR from Fusobacterium nucleatum (FnGR), a Gram-negative anaerobe involved in periodontal disease, was overproduced, purified, and characterized. Unlike most other GRs, FnGR is a pseudosymmetric enzyme, catalyzing the racemization of glutamate enantiomers with similar kinetic parameters (kcatl→d=17.4±0.8s-1,Kml→d=1.04±0.07mM,kcatd→l=26±1s-1,andKmd→l=17.0±0.1mM; pH optimum ∼8.5). Mutational analysis of residue 151 (A151V) located at the entryway to the active site revealed that FnGR is very sensitive to increased steric bulk at this position. Blue native-polyacrylamide gel electrophoresis, Ferguson plot analyses, and cross-linking studies, indicated that FnGR existed predominately as dimers. Unlike Bacillus subtilis GR, the presence of glutamate did not significantly alter the position of the monomer–dimer equilibrium of FnGR.